Cargando…
Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets
BACKGROUND AND METHODS: Highly pathogenic avian influenza (HPAI) viruses constitute a pandemic threat and the development of effective vaccines is a global priority. Sixty adults were recruited into a randomized clinical trial and were intramuscularly immunized with two virosomal vaccine H5N1 (NIBRG...
Autores principales: | Cox, Rebecca J., Major, Diane, Pedersen, Gabriel, Pathirana, Rishi D., Hoschler, Katja, Guilfoyle, Kate, Roseby, Sarah, Bredholt, Geir, Assmus, Jörg, Breakwell, Lucy, Campitelli, Laura, Sjursen, Haakon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493055/ https://www.ncbi.nlm.nih.gov/pubmed/26147369 http://dx.doi.org/10.1371/journal.pone.0131652 |
Ejemplares similares
-
Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge
por: Major, Diane, et al.
Publicado: (2015) -
Matrix‐M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model
por: Pedersen, Gabriel, et al.
Publicado: (2011) -
A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2012) -
Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP
por: Pedersen, Gabriel Kristian, et al.
Publicado: (2011) -
AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses
por: Gao, Feixia, et al.
Publicado: (2022)